APA

Mendes R. E., Flamm R. K., Farrell D. J., Sader H. S. & Jones R. N. (20170411). Telavancin activity tested against Gram-positive clinical isolates from European, Russian and Israeli hospitals (2011-2013) using a revised broth microdilution testing method: redefining the baseline activity of telavancin. : Journal of chemotherapy (Florence, Italy).

Chicago

Mendes Rodrigo E, Flamm Robert K, Farrell David J, Sader Helio S and Jones Ronald N. 20170411. Telavancin activity tested against Gram-positive clinical isolates from European, Russian and Israeli hospitals (2011-2013) using a revised broth microdilution testing method: redefining the baseline activity of telavancin. : Journal of chemotherapy (Florence, Italy).

Harvard

Mendes R. E., Flamm R. K., Farrell D. J., Sader H. S. and Jones R. N. (20170411). Telavancin activity tested against Gram-positive clinical isolates from European, Russian and Israeli hospitals (2011-2013) using a revised broth microdilution testing method: redefining the baseline activity of telavancin. : Journal of chemotherapy (Florence, Italy).

MLA

Mendes Rodrigo E, Flamm Robert K, Farrell David J, Sader Helio S and Jones Ronald N. Telavancin activity tested against Gram-positive clinical isolates from European, Russian and Israeli hospitals (2011-2013) using a revised broth microdilution testing method: redefining the baseline activity of telavancin. : Journal of chemotherapy (Florence, Italy). 20170411.